Our studies focused on periostin, a unique and major contributor of ECM remodelling in the heart; and galectin-3, an established biomarker of heart failure that binds ECM components and transduces or modulates fibrogenic signalling cascades. The gene discussed is LGALS3; the disease is heart failure.